ORIC Pharmaceuticals raises $53M for drugs that attack treatment-resistant cancers
ORIC Pharmaceuticals is being led by Richard Heyman, the serial biopharma entrepreneur behind companies like Aragon Pharmaceuticals, Seragon Pharmaceuticals and Metacrine.